At least it was the third best year as judged by number of journal articles. But there were more than just journal articles! At the start of the year, we had what was probably the best popular article written to date about Marmorkrebs.
It was a slow year for new introductions, but the one in Macau was a significant expansion in Asia.
And finally, I learned of two North American jurisdictions regulating Marmorkebs: Ohio, which seemed to have done it quietly in 2020, and Ontario, which did so quietly starting in 2022.
Previous year end reviews
2008 was the best year ever for Marmorkrebs research
2009 was tied for the best year ever in Marmorkrebs research
2010 was the best year ever for Marmorkrebs research
2011 was not the best year ever for Marmorkrebs research
2012 was an average year for Marmorkrebs research
2013 was the second best year ever for Marmorkrebs research
2014 was a good year for Marmorkrebs research
2015 was the best year ever for Marmorkrebs research
2016 was the best year ever for Marmorkrebs research
2017 was the second best year ever for Marmorkrebs research
2018 was the second best year ever for Marmorkrebs research
2019 was the second best year ever for Marmorkrebs research
2020 was not the best year for Marmorkrebs research
No comments:
Post a Comment